Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000891609 | SCV001035433 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001159847 | SCV001321590 | likely benign | Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Baylor Genetics | RCV001159847 | SCV001521755 | uncertain significance | Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency | 2020-11-19 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ce |
RCV000891609 | SCV002821886 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | MCM4: BS2 |
Diagnostic Laboratory, |
RCV000891609 | SCV001740434 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000891609 | SCV001965132 | uncertain significance | not provided | no assertion criteria provided | clinical testing |